LONZA_LOGO-BIOLOGICS-BLK_RGB
lonza-dps_hero

Overcome Challenges and Secure Successful Technology Transfers of Complex Biological Products in Sterile Manufacturing

Author: Angela Armanni, Senior Director, Global Head MSAT, Drug Product Services, Lonza

A critical area to consider in selecting a CDMO is their ability to successfully complete technology transfers, which involves an intricate set of activities and disciplines that, if done incorrectly, could result in delays and failures that impact the overall success of your end product. Recognizing what it takes to complete this process effectively and efficiently is crucial to selecting the best partner for your project and product needs. This white paper delivers an analysis of critical success factors for effective technology transfer.

Please complete the form below to download the white paper.

All information provided through this form will be shared with Contract Pharma and Lonza Biologics only. If you do not wish to share your information please contact us directly at: . or contact us by mail at Rodman Media, 25 Phillips Parkway, 2nd Floor, Montvale, NJ 07645, USA. Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.